INTEGRA LIFESCIENCES HOLDINGS CORP Deferred Tax Liabilities, Goodwill and Intangible Assets
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Deferred Tax Liabilities, Goodwill and Intangible Assets of $148.63 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $148.63M.
- 2024-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $218.13M.
- 2023-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $168.23M.
- 2022-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $166.89M.
| Period end | Deferred Tax Liabilities, Goodwill and Intangible Assets | Deferred Tax Liabilities, Goodwill and Intangible Assets as first filed |
|---|---|---|
| 2025-12-31 | $148.63M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $218.13M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $168.23M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $166.89M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $152.15M 10-K · filed 2023-02-22 | |
| 2020-12-31 | $90.27M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $150.88M 10-K · filed 2021-02-23 | |
| 2018-12-31 | $144.86M 10-K · filed 2020-02-21 | |
| 2017-12-31 | $146.33M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $215.44M 10-K · filed 2018-03-01 | $216.78M 10-K · filed 2017-02-23 |
| 2015-12-31 | $225.33M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |